144 related articles for article (PubMed ID: 22475909)
1. Intense FDG activity in the brown adipose tissue in omental and mesenteric regions in a patient with malignant pheochromocytoma.
Cheng W; Zhu Z; Jin X; Chen L; Zhuang H; Li F
Clin Nucl Med; 2012 May; 37(5):514-5. PubMed ID: 22475909
[TBL] [Abstract][Full Text] [Related]
2. Hypermetabolic mesenteric brown adipose tissue on dual-time point FDG PET/CT in a patient with benign retroperitoneal pheochromocytoma.
Dong A; Wang Y; Lu J; Zuo C
Clin Nucl Med; 2014 Mar; 39(3):e229-32. PubMed ID: 23455523
[TBL] [Abstract][Full Text] [Related]
3. Unexpected visitor on FDG PET/CT--brown adipose tissue (BAT) in mesentery in a case of retroperitoneal extra-adrenal pheochromocytoma: is the BAT activation secondary to catecholamine-secreting pheochromocytoma?
Joshi PV; Lele VR
Clin Nucl Med; 2012 May; 37(5):e119-20. PubMed ID: 22475922
[TBL] [Abstract][Full Text] [Related]
4. Unusual FDG uptakes of mesenteric brown adipose tissue in a patient with pheochromocytomas.
Li B; Zhang M; Jin J
Nuklearmedizin; 2016 Aug; 55(4):N32-3. PubMed ID: 27492844
[No Abstract] [Full Text] [Related]
5. Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma.
Kuji I; Imabayashi E; Minagawa A; Matsuda H; Miyauchi T
Ann Nucl Med; 2008 Apr; 22(3):231-5. PubMed ID: 18498040
[TBL] [Abstract][Full Text] [Related]
6. [A Case Report : FDG Uptake to Brown Adipose Tissue Activated by Elevated Serum Catecholamine in a Patient with Pheochromocytoma].
Koh Y; Asakura T; Katayama K; Tei N; Harada Y; Nishimura K
Hinyokika Kiyo; 2018 Nov; 64(11):435-438. PubMed ID: 30543742
[TBL] [Abstract][Full Text] [Related]
7. The effect of catecholamines on the glucose uptake in brown adipose tissue demonstrated by (18)F-FDG PET/CT in a patient with adrenal pheochromocytoma.
Yamaga LY; Thom AF; Wagner J; Baroni RH; Hidal JT; Funari MG
Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):446-7. PubMed ID: 17909796
[No Abstract] [Full Text] [Related]
8. Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma.
Fukuchi K; Tatsumi M; Ishida Y; Oku N; Hatazawa J; Wahl RL
Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):601-3. PubMed ID: 15578336
[TBL] [Abstract][Full Text] [Related]
9. Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
Hadi M; Chen CC; Whatley M; Pacak K; Carrasquillo JA
J Nucl Med; 2007 Jul; 48(7):1077-83. PubMed ID: 17574980
[TBL] [Abstract][Full Text] [Related]
10. Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT.
Fikri AS; Kroiss A; Ahmad AZ; Zanariah H; Lau WF; Uprimny C; Donnemiller E; Kendler D; Nordin AJ; Virgolini IJ
Acta Radiol; 2014 Jun; 55(5):631-40. PubMed ID: 24037430
[TBL] [Abstract][Full Text] [Related]
11. Detection of brown adipose tissue by
Santhanam P; Treglia G; Ahima RS
J Clin Hypertens (Greenwich); 2018 Mar; 20(3):615. PubMed ID: 29443440
[No Abstract] [Full Text] [Related]
12. Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.
Puar T; van Berkel A; Gotthardt M; Havekes B; Hermus AR; Lenders JW; van Marken Lichtenbelt WD; Xu Y; Brans B; Timmers HJ
J Clin Endocrinol Metab; 2016 Jan; 101(1):224-32. PubMed ID: 26574955
[TBL] [Abstract][Full Text] [Related]
13. Failure of Classical β-Blocker Carvedilol to Deactivate Brown Adipose Tissue in a Patient With Pheochromocytoma.
Tsechelidis I; El Darazi E; Muteganya R; Weyts K; Goldman S
Clin Nucl Med; 2018 Aug; 43(8):604-605. PubMed ID: 29916915
[TBL] [Abstract][Full Text] [Related]
14. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
[TBL] [Abstract][Full Text] [Related]
15. A child with Burkitt lymphoma with pleural, peritoneal, mesenteric, omental, and renal involvement: diagnostics by FDG PET/CT.
Wang X; Chen Z; Tang G; Zhang X
Clin Nucl Med; 2011 Jul; 36(7):612-5. PubMed ID: 21637077
[TBL] [Abstract][Full Text] [Related]
16. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
17. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not?
Takanami K; Kaneta T; Morimoto R; Satoh F; Nakamura Y; Takase K; Takahashi S
Ann Nucl Med; 2014 Feb; 28(2):145-53. PubMed ID: 24272068
[TBL] [Abstract][Full Text] [Related]
18. FDG Uptake in Brown Adipose Tissue Activated by a β3-Adrenergic Receptor Agonist Prescribed for Overactive Bladder.
Okuyama C; Kikuchi R; Ikeuchi T
Clin Nucl Med; 2020 Aug; 45(8):628-631. PubMed ID: 32453085
[TBL] [Abstract][Full Text] [Related]
19. [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
Mann GN; Link JM; Pham P; Pickett CA; Byrd DR; Kinahan PE; Krohn KA; Mankoff DA
Ann Surg Oncol; 2006 Feb; 13(2):187-97. PubMed ID: 16418883
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT in a Patient With Glomus Vagale Paraganglioma and Eisenmenger Syndrome: Searching for the Missing Link?
Hsu CC; Singh D; Kwan GN; Bhuta S
Clin Nucl Med; 2016 Mar; 41(3):e135-6. PubMed ID: 26673238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
